Sher LD, Wechsler ME, Rabe KF, Maspero JF, et al. Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: An analysis of the phase 3, open-label extension TRAVERSE trial. Chest 2022 Feb 22. pii: S0012-3692(22)00388-9. doi: 10.1016/j.chest.2022.
PMID: 35217003